Reply

Abstract

well as attitudes and perceived barriers to HBV care to contribute to suboptimal HBV care. [2][3][4] System-level factors have included barriers in timely access to specialty clinics or insurance-specific barriers in timely access to antiviral therapies. 5,6 Thus, while existing studies have clearly identified an urgent need to address the poor linkage and retention to care among HBV patients, future efforts to address these existing gaps must take a comprehensive approach that incorporates quality improvement initiatives that target modifiable factors at the patient, provider, and system levels.